These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9462670)

  • 21. Breast cancer chemotherapy-related cognitive dysfunction.
    Ahles TA; Saykin AJ
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S84-90. PubMed ID: 12533268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 23. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.
    Du XL; Xia R; Hardy D
    Am J Clin Oncol; 2010 Dec; 33(6):533-43. PubMed ID: 20023570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
    Jansen CE; Miaskowski C; Dodd M; Dowling G
    Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.
    Nudelman KN; McDonald BC; Saykin AJ
    JAMA Oncol; 2016 Feb; 2(2):174-6. PubMed ID: 26633755
    [No Abstract]   [Full Text] [Related]  

  • 27. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Feasibility and Tolerability of Newer Chemotherapy Regimens in the Adjuvant Setting in Older Patients with Breast Cancer.
    Ladwa R; Sanmugarajah J
    Breast J; 2016; 22(2):244-6. PubMed ID: 26688061
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible.
    Barton D; Loprinzi C
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S121-7. PubMed ID: 12533273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High doses of chemotherapy in the treatment of breast cancer: the current prospects].
    Martin M; Livingston RB
    Rev Clin Esp; 1993 May; 192(8):400-7. PubMed ID: 8511380
    [No Abstract]   [Full Text] [Related]  

  • 36. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulating evidence for the effect of chemotherapy on cognition.
    Rodin G; Ahles TA
    J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
    [No Abstract]   [Full Text] [Related]  

  • 38. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
    Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
    Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
    J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.